Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib

View source ↗

Summary

This clinical trials update describes a study investigating the relationship between gut microbiota and diarrhea in breast cancer patients treated with the tyro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pyrotinib (pyrotinib)

Snippet

Sponsor: Hubei Cancer Hospital | Conditions: Breast Cancer, Drug-Related Side Effects | Status: NOT_YET_RECRUITING